Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant Helicobacter pylori strains: A network meta-analysis

Figure 4 Forest plots of the league matrix in randomized controlled trials among all patients (A) and those infected with clarithromycin-resistant strains (B). A: Vonoprazan-dual therapy; B: Vonoprazan-triple therapy; C: Sequential therapy; D: Dual therapy containing a high-dose proton pump inhibitor; E: Proton pump inhibitor bismuth quadruple therapy; F: Proton pump inhibitor nonbismuth quadruple therapy; G: Proton- pump inhibitor triple therapy. RCTs: Randomized controlled trials; CrI: Credible interval.